Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT02489123 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Accrual goal not met

Conditions

Ann Arbor Stage I Mantle Cell Lymphoma
Ann Arbor Stage II Mantle Cell Lymphoma
Ann Arbor Stage III Mantle Cell Lymphoma
Ann Arbor Stage IV Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma
Refractory Mantle Cell Lymphoma

Interventions

DRUG: Enzalutamide
OTHER: Laboratory Biomarker Analysis

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]